Lataa...
The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
LTX-315 has been developed as an amphipathic cationic peptide that kills cancer cells. Here, we investigated the putative involvement of mitochondria in the cytotoxic action of LTX-315. Subcellular fractionation of LTX-315-treated cells, followed by mass spectrometric quantification, revealed that t...
Tallennettuna:
Julkaisussa: | Oncotarget |
---|---|
Päätekijät: | , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Impact Journals LLC
2015
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4694939/ https://ncbi.nlm.nih.gov/pubmed/26378049 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|